A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT06136741. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rezpegaldesleukin in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis (REZOLVE-AD)
Study identification
- NCT ID
- NCT06136741
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Nektar Therapeutics
- Industry
- Enrollment
- 396 participants
Conditions and interventions
Conditions
Not listed
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 14, 2023
- Primary completion
- May 5, 2025
- Completion
- Dec 30, 2026
- Last update posted
- May 7, 2026
2023 – 2026
United States locations
- U.S. sites
- 28
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nektar Investigative Site | Bryant | Arkansas | 72022 | — |
| Nektar Investigative Site | Fountain Valley | California | 92708 | — |
| Nektar Investigative Site | Los Angeles | California | 90017 | — |
| Nektar Investigative Site | Los Angeles | California | 90025 | — |
| Nektar Investigative Site | Los Angeles | California | 90057 | — |
| Nektar Investigative Site | Santa Monica | California | 90404 | — |
| Nektar Investigative Site | Hialeah | Florida | 33016 | — |
| Nektar Investigative Site | Hollywood | Florida | 33021 | — |
| Nektar Investigative Site | Miami | Florida | 33173 | — |
| Nektar Investigative Site | Miami Lakes | Florida | 33014 | — |
| Nektar Investigative Site | St. Petersburg | Florida | 33705 | — |
| Nektar Investigative Site | Tampa | Florida | 33615 | — |
| Nektar Investigative Site | Marietta | Georgia | 30060 | — |
| Nektar Investigative Site | Clarksville | Indiana | 47129 | — |
| Nektar Investigative Site | Indianapolis | Indiana | 46202 | — |
| Nektar Investigative Site | Louisville | Kentucky | 40241 | — |
| Nektar Investigative Site | Flint | Michigan | 48532 | — |
| Nektar Investigative Site | Troy | Michigan | 48084 | — |
| Nektar Investigative Site | Las Vegas | Nevada | 89106 | — |
| Nektar Investigative Site | New York | New York | 10075 | — |
| Nektar Investigative Site | Fairborn | Ohio | 45324 | — |
| Nektar Investigative Site | Mayfield Heights | Ohio | 44124 | — |
| Nektar Investigative Site | Murfreesboro | Tennessee | 37130 | — |
| Nektar Investigative Site | Bellaire | Texas | 77401 | — |
| Nektar Investigative Site | Cypress | Texas | 77429 | — |
| Nektar Investigative Site | Frisco | Texas | 75034 | — |
| Nektar Investigative Site | Spokane | Washington | 99202-1461 | — |
| Nektar Investigative Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06136741, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06136741 live on ClinicalTrials.gov.